TGA
FUSN

TPG GP A’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History

TPG GP A’s Portfolio FUSN Stock Details FUSN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,551,794
Closed -$54.4M – 40
2024
Q1 		$54.4M Hold
2,551,794
– – 1.04% 26
2023
Q4 		$24.5M Hold
2,551,794
– – 0.4% 30
2023
Q3 		$6.63M Hold
2,551,794
– – 0.11% 35
2023
Q2 		$11.9M Hold
2,551,794
– – 0.18% 35
2023
Q1 		$9.62M Hold
2,551,794
– – 0.16% 34
2022
Q4 		$8.04M Hold
2,551,794
– – 0.16% 34
2022
Q3 		$7.68M Hold
2,551,794
– – 0.13% 34
2022
Q2 		$6.35M Hold
2,551,794
– – 0.1% 35
2022
Q1 		$19.8M Hold
2,551,794
– – 0.25% 35
2021
Q4 		$10.6M Buy
+2,551,794
New +$15.9M 0.11% 36

TPG GP A's FUSN Position: Q2 2024 in Review

TPG GP A sold out of Fusion Pharmaceuticals Inc. Common Shares (FUSN) in Q2 2024, closing a stake of 2,551,794 shares — an estimated $54.4M sold.

TPG GP A first reported a position in FUSN in Q4 2021 and held it in 10 quarters. The position peaked at $54.4M in Q1 2024. 0 funds tracked by Wall St. Rank hold FUSN as of Q2 2024.

  • TPG GP A reported no remaining Fusion Pharmaceuticals Inc. Common Shares position as of Q2 2024 after selling out during the quarter.
  • TPG GP A sold 2,551,794 Fusion Pharmaceuticals Inc. Common Shares shares in Q2 2024, an estimated $54.4M.
  • TPG GP A first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q4 2021 and held it in 10 quarters.
  • TPG GP A's Fusion Pharmaceuticals Inc. Common Shares position peaked at $54.4M in Q1 2024.
  • 0 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q2 2024.

Based on TPG GP A's 13F filing for Q2 2024, filed 14 Aug 2024.